A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India

Objective: The prevalence of anemia during pregnancy is as high as 80% in some sections of the Indian population. Iron therapy in different forms has been found to alleviate anemia and yield good fetomaternal outcome. This study aims to evaluate the efficacy of intravenous iron sucrose (IVIS) versus...

Full description

Saved in:
Bibliographic Details
Main Authors: Maureen P Tigga, Amulya P Debbarma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Tzu Chi Medical Journal
Subjects:
Online Access:http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2020;volume=32;issue=3;spage=258;epage=261;aulast=Tigga
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850251049893363712
author Maureen P Tigga
Amulya P Debbarma
author_facet Maureen P Tigga
Amulya P Debbarma
author_sort Maureen P Tigga
collection DOAJ
description Objective: The prevalence of anemia during pregnancy is as high as 80% in some sections of the Indian population. Iron therapy in different forms has been found to alleviate anemia and yield good fetomaternal outcome. This study aims to evaluate the efficacy of intravenous iron sucrose (IVIS) versus oral iron in treating anemia among the antenatal mothers attending a tertiary care center of Northeast India. Materials and Methods: One hundred women between 18 and 28 weeks of gestation with diagnosed iron-deficiency anemia and hemoglobin (Hb) of 7–10.9 g/dL were enrolled to be administered either oral ferrous sulfate 200 mg twice daily or requisite dose of IVIS 100 mg in 100 ml normal saline on alternate days. Hb and hematocrit were measured at the time of enrollment, 4th week, and 8th week of therapy. Acceptability of both the drugs based on like and dislike after interviewing the study participants was recorded. Adverse drug reactions, gestational age at delivery, and neonatal birth weight were also noted in both the groups. The results were analyzed by Student's t-test and Chi-square test. Results: Hb and hematocrit values were found to be increased in both the groups at 4th and 8th weeks. When both the groups were compared, the rise in the values was higher in the iron sucrose group (at 4th week P = 0.01 and at 8th week P = 0.00). The number of participants who reached target Hb levels at 4 weeks was 41 (82%) with oral iron and 48 (96%) with iron sucrose. In the iron sucrose group, no adverse effects were observed, suggesting its safety, and the acceptability and newborn birth weight were noted to be higher. Conclusion: IVIS was found to be more effective than oral iron therapy in treating antenatal anemia with no serious adverse drug reactions.
format Article
id doaj-art-7ad8a4a83cea4cabafe86eb865b133bc
institution OA Journals
issn 1016-3190
2223-8956
language English
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Tzu Chi Medical Journal
spelling doaj-art-7ad8a4a83cea4cabafe86eb865b133bc2025-08-20T01:58:00ZengWolters Kluwer Medknow PublicationsTzu Chi Medical Journal1016-31902223-89562020-01-0132325826110.4103/tcmj.tcmj_99_19A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast IndiaMaureen P TiggaAmulya P DebbarmaObjective: The prevalence of anemia during pregnancy is as high as 80% in some sections of the Indian population. Iron therapy in different forms has been found to alleviate anemia and yield good fetomaternal outcome. This study aims to evaluate the efficacy of intravenous iron sucrose (IVIS) versus oral iron in treating anemia among the antenatal mothers attending a tertiary care center of Northeast India. Materials and Methods: One hundred women between 18 and 28 weeks of gestation with diagnosed iron-deficiency anemia and hemoglobin (Hb) of 7–10.9 g/dL were enrolled to be administered either oral ferrous sulfate 200 mg twice daily or requisite dose of IVIS 100 mg in 100 ml normal saline on alternate days. Hb and hematocrit were measured at the time of enrollment, 4th week, and 8th week of therapy. Acceptability of both the drugs based on like and dislike after interviewing the study participants was recorded. Adverse drug reactions, gestational age at delivery, and neonatal birth weight were also noted in both the groups. The results were analyzed by Student's t-test and Chi-square test. Results: Hb and hematocrit values were found to be increased in both the groups at 4th and 8th weeks. When both the groups were compared, the rise in the values was higher in the iron sucrose group (at 4th week P = 0.01 and at 8th week P = 0.00). The number of participants who reached target Hb levels at 4 weeks was 41 (82%) with oral iron and 48 (96%) with iron sucrose. In the iron sucrose group, no adverse effects were observed, suggesting its safety, and the acceptability and newborn birth weight were noted to be higher. Conclusion: IVIS was found to be more effective than oral iron therapy in treating antenatal anemia with no serious adverse drug reactions.http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2020;volume=32;issue=3;spage=258;epage=261;aulast=Tiggairon-deficiency anemiairon sucroseoral iron therapy
spellingShingle Maureen P Tigga
Amulya P Debbarma
A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India
Tzu Chi Medical Journal
iron-deficiency anemia
iron sucrose
oral iron therapy
title A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India
title_full A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India
title_fullStr A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India
title_full_unstemmed A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India
title_short A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India
title_sort comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of northeast india
topic iron-deficiency anemia
iron sucrose
oral iron therapy
url http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2020;volume=32;issue=3;spage=258;epage=261;aulast=Tigga
work_keys_str_mv AT maureenptigga acomparativestudytoevaluateoralironandintravenousironsucrosefortreatmentofanemiainpregnancyinapoorsocioeconomicregionofnortheastindia
AT amulyapdebbarma acomparativestudytoevaluateoralironandintravenousironsucrosefortreatmentofanemiainpregnancyinapoorsocioeconomicregionofnortheastindia
AT maureenptigga comparativestudytoevaluateoralironandintravenousironsucrosefortreatmentofanemiainpregnancyinapoorsocioeconomicregionofnortheastindia
AT amulyapdebbarma comparativestudytoevaluateoralironandintravenousironsucrosefortreatmentofanemiainpregnancyinapoorsocioeconomicregionofnortheastindia